-
Product Insights
Ewing Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Ewing's sarcoma is a primary bone cancer that affects mainly children and adolescents. Ewing's sarcoma can occur any time during childhood and young adulthood, but usually develops during puberty, when bones are growing rapidly. The Ewing Sarcoma pipeline drugs market research report provides comprehensive information on the therapeutics under development for Ewing Sarcoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological...
-
Product Insights
Retinoblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Retinoblastoma may occur with symptoms including white color in the center circle of the eye (pupil), eye redness, vision problems, a different color in each iris and eye swelling. The predisposing factors include age and heredity. Treatment includes chemotherapy, radiation therapy and surgery. The retinoblastoma pipeline drugs market research report provides an analysis of the retinoblastoma drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The guide also covers the descriptive...
-
Product Insights
Pulmonary Arterial Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Pulmonary arterial hypertension pipeline market research report provides comprehensive information on the therapeutics under development for Pulmonary Arterial Hypertension, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pulmonary Arterial Hypertension and...
-
Product Insights
Osteosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Osteosarcoma is the most common cancer of the bone that destroys tissue and weakens the bone. It is developed from immature bone cells that normally form new bone tissue. Osteosarcoma Drugs in Development market research report provides comprehensive information on the therapeutics under development for Osteosarcoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research...
-
Product Insights
Acute Respiratory Distress Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The acute respiratory distress syndrome pipeline market research report provides comprehensive information on the therapeutics under development for Acute Respiratory Distress Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Acute...
-
Product Insights
Pediatric Cancer Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Pediatric Cancer Global Clinical Trials Review, H1, 2018" provides an overview of Pediatric Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pediatric Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Track & Monitor
PharmSource – Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars – 2018 Edition
Biosimilars are drugs that are highly similar but not identical to branded “innovator” biologics: large molecule, immunogenic drugs produced from living cells. “Innovator” biologics are the first to be approved, and when their patent protection expires, biosimilars may be approved, in a similar way to small molecule branded drugs and their generics. There are no clinically meaningful differences in quality, safety and efficacy between biosimilars and innovator biologics. The exact definition of a biosimilar varies by regulator. Biosimilars bring competition...
-
Track & Monitor
Monthly Mining Industry Deals Review – August 2018
GlobalData's “Monthly Mining Industry Deals Review – August 2018” report is an essential source of data and trend analysis on M&A (mergers, acquisitions, and asset transactions), in the mining industry. The report provides detailed comparative monthly data on the number of deals and their value, sub-divided into deal types, by status, by region, and country. The report also highlights top buyers and sellers by region in addition to top announced and completed deals by value globally.
-
Product Insights
Radiodermatitis Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Radiodermatitis Global Clinical Trials Review, H1, 2018" provides an overview of Radiodermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Radiodermatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Radiodermatitis Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Radiodermatitis Global Clinical Trials Review, H1, 2016" provides an overview of Radiodermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Radiodermatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...